These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 10880677)

  • 41. Opposite effects of sulpiride and SCH 23390 on ethanol-induced striatal ascorbic acid release in intact and 6-hydroxydopamine lesioned rats.
    Liu W; Wu CF; Huang M; Xiao K
    Brain Res; 2000 Jun; 869(1-2):31-8. PubMed ID: 10865056
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Priming of 6-hydroxydopamine-lesioned rats with L-DOPA or quinpirole results in an increase in dopamine D1 receptor-dependent cyclic AMP production in striatal tissue.
    Pinna A; Morelli M; Drukarch B; Stoof JC
    Eur J Pharmacol; 1997 Jul; 331(1):23-6. PubMed ID: 9274925
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Neonatal and adult 6-hydroxydopamine-induced lesions differentially alter tachykinin and enkephalin gene expression.
    Sivam SP; Breese GR; Krause JE; Napier TC; Mueller RA; Hong JS
    J Neurochem; 1987 Nov; 49(5):1623-33. PubMed ID: 2889804
    [TBL] [Abstract][Full Text] [Related]  

  • 44. SCH 23390-induced behavioral supersensitivity is not related to striatal c-fos levels.
    Muñoz JE; Marín C; Tolosa E
    Brain Res; 1997 Nov; 774(1-2):51-4. PubMed ID: 9452191
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Lack of synergism between caffeine and SKF 38393 on rotational behavior in 6-hydroxydopamine-denervated rats.
    Casas M; Prat G; Rubio A; Barbanoj M; Jané F
    Eur J Pharmacol; 2000 May; 396(2-3):93-9. PubMed ID: 10822061
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effects of intrasubthalamic injection of dopamine receptor agonists on subthalamic neurons in normal and 6-hydroxydopamine-lesioned rats: an electrophysiological and c-Fos study.
    Hassani OK; Féger J
    Neuroscience; 1999; 92(2):533-43. PubMed ID: 10408602
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Phencyclidine supersensitivity in rats with neonatal dopamine loss.
    Moy SS; Breese GR
    Psychopharmacology (Berl); 2002 May; 161(3):255-62. PubMed ID: 12021828
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The regulation of dopamine release from nigrostriatal neurons in conscious rats: the role of somatodendritic autoreceptors.
    Santiago M; Westerink BH
    Eur J Pharmacol; 1991 Oct; 204(1):79-85. PubMed ID: 1687125
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Dopamine control of seizure propagation: intranigral dopamine D1 agonist SKF-38393 enhances susceptibility to seizures.
    Turski WA; Cavalheiro EA; Ikonomidou C; Bortolotto ZA; Klockgether T; Turski L
    Synapse; 1990; 5(2):113-9. PubMed ID: 2137942
    [TBL] [Abstract][Full Text] [Related]  

  • 50. D1 dopamine receptors influence Fos immunoreactivity in the globus pallidus and subthalamic nucleus of intact and nigrostriatal-lesioned rats.
    Ruskin DN; Marshall JF
    Brain Res; 1995 Dec; 703(1-2):156-64. PubMed ID: 8719628
    [TBL] [Abstract][Full Text] [Related]  

  • 51. α4 nicotinic acetylcholine receptor modulated by galantamine on nigrostriatal terminals regulates dopamine receptor-mediated rotational behavior.
    Inden M; Takata K; Yanagisawa D; Ashihara E; Tooyama I; Shimohama S; Kitamura Y
    Neurochem Int; 2016 Mar; 94():74-81. PubMed ID: 26911419
    [TBL] [Abstract][Full Text] [Related]  

  • 52. D1 and D2 dopamine receptor antagonists block caffeine-induced stimulation of locomotor activity in rats.
    Garrett BE; Holtzman SG
    Pharmacol Biochem Behav; 1994 Jan; 47(1):89-94. PubMed ID: 7906891
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Interactions of dopaminergic and GABAergic neurotransmission: impact of 6-hydroxydopamine lesions into the substantia nigra of rats.
    Hossain MA; Weiner N
    J Pharmacol Exp Ther; 1995 Oct; 275(1):237-44. PubMed ID: 7562556
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Subchronic caffeine administration sensitizes rats to the motor-activating effects of dopamine D(1) and D(2) receptor agonists.
    Cauli O; Morelli M
    Psychopharmacology (Berl); 2002 Jul; 162(3):246-54. PubMed ID: 12122482
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Adenosine receptor antagonists potentiate dopamine receptor agonist-induced rotational behavior in 6-hydroxydopamine-lesioned rats.
    Jiang H; Jackson-Lewis V; Muthane U; Dollison A; Ferreira M; Espinosa A; Parsons B; Przedborski S
    Brain Res; 1993 Jun; 613(2):347-51. PubMed ID: 8186990
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Continuous and intermittent levodopa differentially affect rotation induced by D-1 and D-2 dopamine agonists.
    Engber TM; Susel Z; Juncos JL; Chase TN
    Eur J Pharmacol; 1989 Sep; 168(3):291-8. PubMed ID: 2573533
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Dopamine supersensitivity and D1/D2 synergism are unrelated to changes in striatal receptor density.
    LaHoste GJ; Marshall JF
    Synapse; 1992 Sep; 12(1):14-26. PubMed ID: 1357762
    [TBL] [Abstract][Full Text] [Related]  

  • 58. EEG modifications in the cortex and striatum after dopaminergic priming in the 6-hydroxydopamine rat model of Parkinson's disease.
    Vorobyov VV; Schibaev NV; Morelli M; Carta AR
    Brain Res; 2003 May; 972(1-2):177-85. PubMed ID: 12711091
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Supersensitization of intrastriatal dopamine receptors involved in opposite regulation of acetylcholine release in Parkinson's model rats.
    Sato K; Ueda H; Okumura F; Misu Y
    Neurosci Lett; 1994 May; 173(1-2):59-62. PubMed ID: 7936424
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Restoration of complex sensorimotor behavior and skilled forelimb use by a modified nigral cell suspension transplantation approach in the rat Parkinson model.
    Nikkhah G; Duan WM; Knappe U; Jödicke A; Björklund A
    Neuroscience; 1993 Sep; 56(1):33-43. PubMed ID: 8232915
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.